Singapore Steps Up Enforcement and Crackdown on E-Cigarettes

Regulations by 2FIRSTS.ai
Dec.20.2023
Singapore Steps Up Enforcement and Crackdown on E-Cigarettes
Singapore's health ministry aims to crack down on the sale and use of e-cigarettes, despite a ban, by ramping up enforcement efforts.

According to a report by Singapore's Lianhe Zaobao on December 19, the Singapore Ministry of Health has pointed out that despite the ban on the sale and use of e-cigarettes in the country, there are still avenues for the public to purchase them. In response to this situation, the Ministry of Health plans to intensify joint enforcement efforts and raising public awareness to combat the circulation of e-cigarettes.

 

In a joint statement issued on December 19th last year, the Ministry of Health and the Health Science Bureau announced their findings that the public can still obtain e-cigarettes through chatting applications such as Telegram or while traveling abroad. In an effort to prevent further deterioration of the e-cigarette issue in the country, the Ministry of Health, along with other government agencies, intends to strengthen enforcement measures and awareness campaigns regarding e-cigarettes.

 

In recent times, the Health Sciences Authority (HSA) has announced a joint operation with the Immigration and Checkpoints Authority (ICA) to carry out enforcement measures at ports, land checkpoints, and airports, starting from Changi Airport. The primary objective of this operation is to crack down on incoming passengers carrying e-cigarettes, with violators being subject to fines. The HSA will also collaborate with the Ministry of Communications and Information and the Infocomm Media Development Authority to enhance the monitoring and prohibition of e-cigarette online sales and advertising.

 

In addition, the Ministry of Health, in collaboration with the Ministry of Education, the National Environmental Agency, the National Parks Board, and the Singapore Police Force, has ramped up enforcement efforts regarding the possession and use of e-cigarettes. Since December 1st of last year, enforcement officers from the Environmental Agency have been authorized to take action against individuals found using or possessing e-cigarettes, with some cases being passed on to the Health Sciences Authority for further investigation.

 

Inspections at public places such as central business districts, shopping centers, parks, smoking areas, bars, and clubs will also be intensified, with violators facing on-the-spot fines. In schools, if students are found using or in possession of e-cigarettes, the school authorities will confiscate the e-cigarette, inform parents, and report the incident to the Department of Health, to ensure strict punishment for such violations.

 

According to the latest data released by the Health Science Bureau, from 2018 to 2022, a total of 860 individuals have been involved in the sale and smuggling of e-cigarettes and their accessories, with 145 of them being brought to court. Last year, the number of arrests for using and possessing e-cigarettes reached 4,916, nearly triple the figure from 2020. In the period from April to August this year, 18 individuals were sentenced for selling e-cigarettes and their accessories.

 

According to Minister Wong Yi Kang's response to written queries in Parliament last November, approximately 20% of the individuals arrested for purchasing or possessing e-cigarettes in the first nine months of last year were under the age of 18.

 

According to tobacco regulations, the import, distribution, or sale of e-cigarettes is considered illegal. First-time offenders can face a maximum fine of SGD 10,000 or six months of imprisonment, or both. Repeat offenders can be fined SGD 20,000, imprisoned for one year, or both. Individuals found in possession of, using, or purchasing e-cigarettes may face a maximum fine of SGD 2,000.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14